Role of tirofiban in treatment of stent thrombosis

References (7)

1. Mak K-H, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis; evolving issues and current concepts. J Am Coll Cardiol 1996;27:494-503
2. Timurkaynak T, Cemri M, Ozdemir M, et al. Intracoronary tirofiban infusion in a case with massive intracoronary thrombus. J Invas Cardiol 2001;13:654-6 3. PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-97
3. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy) - Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87
4. GUSTO IV- ACS Investigators.Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet 2001; 357: 1899-900
5. The CAPTURE Investigators. Randomized placebo controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997;349:1429-35
6. Topol EJ, Moliterno DJ, Hermann HC, Powers ER, Grines CL, Cohen DJ, et al. TARGET Investigators. Do Tirofiban and ReoPro Give Similar Efficacy Trial. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med 2001; 344: 1888-94
7. Casserly IP, Hasdai D, Berger PB, Holmes DR Jr, Schwartz RS, Bell MR. Usefulness of abciximab for treatment of early coronary artery stent thrombosis. Am J Cardiol 1998;82:981-5.